Updated:
Enclara Pharmacia
Enclara Pharmacia operates as a pharmacy solutions provider exclusively for the hospice and palliative care community.
Enclara Pharmacia
Enclara Pharmacia operates as a pharmacy solutions provider exclusively for the hospice and palliative care community. Its Pennsylvania fulfillment center first opened nearly two decades ago, and the company has since added a Tennessee facility to support its national mail-order program. Neither a family office nor an investment manager, Enclara is a subsidiary of Dragonfly Health, which also offers DME and combined service solutions (per firm website). The company's core service line includes local pharmacy claims processing, a full-service mail-order pharmacy with next-day delivery, dedicated inpatient unit support, and non-sterile compounding, ComfortPak processing, and prefilled syringe packaging. Enclara's E3 Pro platform provides web and mobile ordering with EMR integration; robotic dispensing units fill, label, and cap a pill bottle in about 30 seconds (per firm blog, November 2024). The firm serves hospice providers of all sizes across the United States. Enclara reports no AUM, total professionals count, or founding year on its public website. The firm employees a team of pharmacists, pharmacy technicians, IT professionals, and support staff across its two fulfillment sites. In November 2024, Enclara described a technology upgrade at its Pennsylvania facility (per firm blog, November 2024). Enclara's structural differentiator is its exclusive focus on hospice pharmacy — a niche that combines medication management technology, 24/7 clinical pharmacist consults, and educational resources for hospice nurses. The company does not market to general healthcare systems but to the hospice IPU (inpatient unit) landscape, where timing and medication access are critical.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Philadelphia
Corporate office
1601 Cherry Street Suite 1800 Philadelphia, PA 19102, United States
Additional offices
Tennessee
Principals
Sherin Kuruvilla
PharmD.
Josh Paire
Vice President of Pharmacy Operations
Sector focus
Frequently asked questions
Who runs investment decisions at Enclara Pharmacia?
Enclara Pharmacia is not an investment manager — it is a pharmacy solutions provider for hospice care. The company's leadership includes a corporate management team; VP of Pharmacy Operations Josh Paire oversees fulfillment operations. No CIO or investment committee is identified on the public website.
Is Enclara Pharmacia structured as a single family office or does it operate more like a venture firm?
Neither. Enclara is a healthcare services company and a subsidiary of Dragonfly Health. It does not manage family capital, make equity investments, or operate a fund. Its business is pharmacy benefits management, medication dispensing, and clinical support for hospice providers.
What investment stages does Enclara typically target?
Enclara does not target investment stages. It is a pharmacy services company, not an investment firm. No venture, private equity, or fund commitments are disclosed on its website.
Which sectors does Enclara explicitly avoid?
Enclara only serves the hospice and palliative care community. It does not serve general healthcare, retail customers, or other segments.
How is Enclara related to Dragonfly Health?
Enclara is a Dragonfly Health company (per firm website). Dragonfly Health offers combined pharmacy, DME, and service solutions nationally. The relationship is parent-subsidiary, though Enclara operates as a distinct brand focused on hospice pharmacy.
Where does the underlying wealth come from?
This question is not applicable — Enclara is not a family office or wealth manager. It is an operating healthcare company. No wealth origin is disclosed.
Does Enclara maintain philanthropic structures, and how are they separated?
Enclara's website does not mention any foundation, charitable trust, or philanthropic arm. The firm's activities are entirely commercial in the hospice pharmacy space.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: